REQUEST A DEMO
Total
USD $0.00
Search more companies

Noble Medicine Premium Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Marketing Research and Public Opinion Polling | Ambulatory Health Care Services
Full name: Noble Medicine Premium Sp. z o.o. Profile Updated: November 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Noble Medicine Premium Sp. z o.o. is a company in Poland, with a head office in Warsaw. The enterprise currently operates in the General Medical and Surgical Hospitals sector. Noble Medicine Premium Sp. z o.o. was incorporated on August 11, 2017. The company’s latest financial report indicates a net sales revenue drop of 38.89% in 2023. Its’ total assets recorded a negative growth of 21.82%. The net profit margin of Noble Medicine Premium Sp. z o.o. increased by 10.03% in 2023.

Headquarters
Ul. Adama Naruszewicza 27/2
Warsaw; Mazowieckie; Postal Code: 02-627

Contact Details: Purchase the Noble Medicine Premium Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Noble Medicine Premium Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Noble Medicine Premium Sp. z o.o. report to view the information.
Incorporation Date:
August 11, 2017
Ownership Details
Purchase this report to view the information.
74.86%
Purchase this report to view the information.
25.14%
Company Performance
Financial values in the chart are available after Noble Medicine Premium Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-38.89%
Total operating revenue
-37.61%
Operating profit (EBIT)
71.61%
EBITDA
80.75%
Net Profit (Loss) for the Period
77.28%
Total assets
-21.82%
Total equity
-13.07%
Operating Profit Margin (ROS)
6.81%
Net Profit Margin
10.03%
Return on Equity (ROE)
42.5%
Debt to Equity Ratio
-0.52%
Quick Ratio
0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?